Tax Implications of ESOPs
Employee Stock Option Plans (ESOPs) are taxed twice under the Indian income tax framework — first as a perquisite under Section 17(2)(vi) when shares are allotted upon exercise (taxed as salary), and second as capital gains when the shares are subsequently sold, creating a double-taxation effect on the value created during the vesting period.
ESOPs in India were treated as a perquisite — a non-cash benefit provided by the employer — under Section 17(2)(vi) of the Income Tax Act. When an employee exercised the option and received shares, the spread between the fair market value (FMV) on the date of exercise and the exercise price paid by the employee was treated as a taxable perquisite. This perquisite value was added to the employee's gross salary and taxed at the applicable slab rate — up to 30% plus surcharge and cess.
For listed company shares, FMV on the exercise date was the average of the opening and closing price on the stock exchange on the date of exercise (or the previous day's closing price if the shares were not traded on the exercise date). For unlisted company shares, FMV was determined by a Category I Merchant Banker registered with SEBI, as per Rule 3(9) of the Income Tax Rules. The unlisted FMV determination was more complex and introduced subjectivity, though the Rule attempted to standardise the approach.
The employer was required to deduct TDS on the perquisite value at the time of allotment of shares under the exercise. For listed shares, the employer sold a portion of the allotted shares (or collected cash from the employee) to cover the TDS liability. This sell-to-cover mechanism meant that employees who intended to hold their shares long-term faced an involuntary partial sale at exercise, reducing the shares held and creating a capital gains event in the same transaction.
Upon the subsequent sale of ESOP shares, capital gains tax applied. The cost of acquisition for the purpose of computing capital gains was the FMV on the date of exercise (since the employee had already paid tax on this FMV as salary income). The gain was the difference between the sale price and the FMV on the exercise date. If shares were held for more than twelve months from the date of allotment (for listed shares), the gain qualified as long-term capital gains taxable at 12.5% without indexation under Section 112A (post-Budget 2024). Short-term capital gains for listed shares held under twelve months were taxed at 20% under Section 111A.
For startups and unlisted companies, a deferral mechanism was introduced by the Finance Act 2020. Instead of paying tax on the perquisite at the time of exercise, eligible ESOP holders in eligible startups (as defined under DPIIT recognition) could defer the tax payment to the earlier of the sale of shares, leaving the employment, or five years from the year of allotment. This deferral was an important policy concession for cash-constrained startup employees who received significant ESOP grants but had no liquidity to pay the perquisite tax at exercise without selling shares.
The double-taxation nature of ESOPs meant that employees' total effective tax on ESOP value creation could be extremely high. Consider an employee who received ESOPs at an exercise price of Rs 100, exercised when FMV was Rs 500 (paying 30% on Rs 400 as perquisite), then sold at Rs 800. The capital gain of Rs 300 (Rs 800 minus Rs 500 FMV at exercise) was taxed at 12.5%. The combined tax on the Rs 700 value creation (Rs 800 sale price minus Rs 100 exercise price) was Rs 120 perquisite tax plus Rs 37.5 capital gains tax — an effective rate of about 22.5% on total value, though the perquisite tax was paid at a time when no cash was received, creating a liquidity mismatch that was the primary practical complaint of ESOP beneficiaries.